Alland Leila
SEC insider (Form 3/4/5 filer). CIK 0001825216. Chief Medical Officer at Cardiff Oncology, Inc. (CRDF) and 1 other issuer. 4 reported Form 4/5 transactions since Sep 2024; latest on Jun 30, 2026. Located in SAN DIEGO, CA.
Companies Alland Leila has filed insider reports for
- Cardiff Oncology, Inc. (CRDF): Officer, Chief Medical Officer
- ABEONA THERAPEUTICS INC. (ABEO): Director
Alland Leila
CIK: 0001825216
Transaction Breakdown
Open Market Buys (P)0 (0.0%)
High conviction signal
Open Market Sales (S)2 (50.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)2 (50.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Jun 30, 2026ABEO
ABEONA THERAPEUTICS INC.
SaleDirect11K shares at avg. $5.92$65K - Feb 2, 2026ABEO
ABEONA THERAPEUTICS INC.
SaleDirect18.1K shares at avg. $5.09$92K - Jan 26, 2026ABEO
ABEONA THERAPEUTICS INC.
AwardDirect37.3K shares- - Jan 31, 2025ABEO
ABEONA THERAPEUTICS INC.
AwardDirect36.1K shares-
1-4 of 4 transactions